---
schema_version: "secwatch.filing_event.v1"
accession: "0001964738-24-000017"
form_type: "8-K"
ticker: "SOLV"
cik: "0001964738"
company_name: "Solventum Corp"
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T11:21:01.292756+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Solventum Q2 GAAP EPS $0.51, adj EPS $1.56; raises full-year guidance

## Summary
- Reported sales $2.081B (+0.2% YoY); organic sales +1.3%; MedSurg and HIS drove growth.
- GAAP operating margin 11.7%; adjusted operating margin 20.7%; adjusted EPS $1.56.
- Generated $355M cash from ops; free cash flow $297M.
- Raises full-year 2024 organic sales growth and adjusted EPS guidance.

## SEC filing metadata
- accession: 0001964738-24-000017
- form_type: 8-K
- ticker: SOLV
- cik: 0001964738
- company_name: Solventum Corp
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964738/000196473824000017/0001964738-24-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964738/000196473824000017/solv-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001964738-24-000017
- JSON: https://secwatch.observer/filing/0001964738-24-000017.json
- Plain text: https://secwatch.observer/filing/0001964738-24-000017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.